147 related articles for article (PubMed ID: 8668346)
1. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel.
Fujii M; Minamino T; Nomura M; Miyamoto KI; Tanaka J; Seiki M
Oncogene; 1996 May; 12(10):2193-202. PubMed ID: 8668346
[TBL] [Abstract][Full Text] [Related]
2. v-Rel activates the proto-oncogene c-Jun promoter: a correlation with its transforming activity.
Fujii M; Minamino T; Nomura M; Miyamoto K; Tanaka J; Seiki M
Leukemia; 1997 Apr; 11 Suppl 3():402-4. PubMed ID: 9209405
[TBL] [Abstract][Full Text] [Related]
3. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
Sif S; Capobianco AJ; Gilmore TD
Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
[TBL] [Abstract][Full Text] [Related]
4. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
5. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
6. Differential and antagonistic effects of v-Jun and c-Jun.
Gao M; Morgan I; Vogt PK
Cancer Res; 1996 Sep; 56(18):4229-35. PubMed ID: 8797597
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
8. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
9. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
Parra E; McGuire K; Hedlund G; Dohlsten M
J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
12. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product.
Schönthal A; Feramisco JR
New Biol; 1990 Feb; 2(2):143-50. PubMed ID: 2150599
[TBL] [Abstract][Full Text] [Related]
13. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
Gélinas C; Temin HM
Oncogene; 1988 Oct; 3(4):349-55. PubMed ID: 2856247
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.
Bhat GV; Temin HM
Oncogene; 1990 May; 5(5):625-34. PubMed ID: 2189101
[TBL] [Abstract][Full Text] [Related]
15. The viral and cellular Rel oncoproteins induce the differentiation of P19 embryonal carcinoma cells.
Inuzuka M; Ishikawa H; Kumar S; Gélinas C; Ito Y
Oncogene; 1994 Jan; 9(1):133-40. PubMed ID: 8302572
[TBL] [Abstract][Full Text] [Related]
16. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
17. Structure and autoregulation of the c-rel promoter.
Hannink M; Temin HM
Oncogene; 1990 Dec; 5(12):1843-50. PubMed ID: 2284104
[TBL] [Abstract][Full Text] [Related]
18. Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1.
Castellanos MC; Muñoz C; Montoya MC; Lara-Pezzi E; López-Cabrera M; de Landázuri MO
J Immunol; 1997 Dec; 159(11):5463-73. PubMed ID: 9580241
[TBL] [Abstract][Full Text] [Related]
19. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
[TBL] [Abstract][Full Text] [Related]
20. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
Fan Y; Gélinas C
Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
